Tempus picks up $110 mln
Chicago-based Tempus, a data-driven precision medicine company, has raised $110 million in financing. The investors included Baillie Gifford, T. Rowe Price, Revolution Growth and New Enterprise Associates.
31 August 2018•1 min read
